Track market-moving stories before they get noisy

PepsiCo CEO Ramon Laguarta discusses efforts to grow the company faster in the U.S. and consumer prices on 'The Claman Countdown.' #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #theclamancountdown #pepsico #ramonlaguarta #business #economy #consumer #prices #inflation #growth #market #stocks #investing #retail #food #beverages #company #corporate #finance #manufacturing

Luke Lango highlights AI’s toll roads… Brian Hunt flags Brazil’s overlooked AI angle… Louis Navellier’s refiner play amid Mideast turmoil… As I write on Thursday morning, the biggest headline is that President Trump says Iran called “a little while ago” wanting to make a deal “so badly” – just hours after a second night of U.S. strikes.

But there are plenty of other stories…

South Korean memory-chip maker SK Hynix – one of the world’s most recently minted trillion-dollar companies – is preparing for its $28 billion American IPO tomorrow. Demand is running roughly seven times the available shares, a loud signal for the AI memory trade.

Meanwhile, on the economic front, this morning’s initial jobless claims came in at a seasonally adjusted 215,000, beating forecasts and down from the prior week. It’s another sign the labor market is holding steady – and a data point that Fed Chair Kevin Warsh will factor in.

We could spend this Digest chasing any one of those threads. Instead, we’re letting them take a backseat for a different purpose…

Putting some money in your pocket.

Today, let’s look at three investment ideas – straight from three of our sharpest analysts.

The first is a straightforward AI play from Luke Lango – built for when the AI trade’s current multiweek drawdown eventually gives way to its next leg higher.

The second is a more conservative way to ride that same AI wave, courtesy of Brian Hunt – and it comes from a corner of the market most investors aren’t watching.

And the third is for AI-weary investors who just need a break from all-things-tech and its recent volatility. It’s a trade from legendary investor Louis Navellier, built around one of the more overlooked side effects of the conflict in the Middle East.

Let’s get into it.

Luke Lango: “AI just joined the payroll” Luke, our tech and innovation expert and editor of Innovation Investor, is flagging a shift he thinks most investors are underestimating. AI is turning from a tool people use into labor companies deploy.

This is the shift to “agentic” AI that we’ve been tracking here in the Digest for months.

To illustrate, Luke highlights Kalshi, the prediction-market platform. It has an internal AI agent named “Harrison” doing work that looks like analyst labor – tracking news, monitoring competitors, drafting contract language, and helping resolve markets.

Tying into the investment opportunities, here’s Luke to explain why that matters for the compute build-out:

An AI agent is different.

Give it an objective, and it goes to work — planning, executing, checking its own output, calling tools, querying databases, revising, and iterating until the task is complete.

That continuous loop consumes inference compute on a vastly larger scale.

This reference to “inference compute” is where we find opportunity.

Luke points to estimates from Gartner that agentic AI workflows consume 5X to 30X more tokens per task than single-shot generative AI queries. Meanwhile, Goldman Sachs projects that monthly token counts for agentic AI could reach roughly 120 quadrillion by 2030.

Luke’s takeaway for investors:

Follow the compute, and you’ll find the trade. 

It doesn’t matter which app wins, which enterprise deploys the most agents, or which model — GPT, Claude, Gemini, Llama — powers them.

What matters is that every agent is sending traffic through the same physical infrastructure stack. And that stack is finite, expensive to build, and currently being stretched to its limits.

Each layer collects a different kind of toll.

Luke breaks the “toll roads” into several categories – accelerators like Nvidia (NVDA), networking and custom silicon such as Credo (CRDO), memory like SanDisk (SNDK), servers and power such as Dell (DELL), optical connectivity like Coherent (COHR), and storage.

For our purpose today, I’ll highlight one of Luke’s “storage” stocks: Everpure (P).

AI agents need fast retrieval from massive datasets, and Luke says storage is where that need shows up first. Here he is with more:

Everpure in particular has been gaining strength beneath the surface.

In Q1 of FY2027, product revenue surged 55%, while subscription services accounted for 45% of total revenue.

Operating profit jumped over 90% year-over-year to $159 million.

His broader point is that as agentic workloads scale, storage isn’t a side character in the AI story; it’s a structural beneficiary. It quietly compounds while the market’s attention stays fixed on chips.

Luke’s closing thought is interesting. While we’ve written many Digests about the economic incentive for companies to shift from a human workforce to an agentic workforce to benefit from lower labor costs, Luke spots a parallel:

Once AI joins the payroll, compute becomes the new labor cost.

The companies supplying the accelerators, networking, memory, servers, storage, power, cooling, and connectivity behind that shift are not side bets on AI. They are the trade.

It’ll be interesting to watch how pricy this new compute “labor cost” becomes – and how that shapes the agentic AI trade.

In the meantime, for the specific AI stocks that Luke officially recommends in Innovation Investor, click here to learn more.

Brian Hunt: Brazil is the AI trade nobody’s talking about Following Luke’s look at the infrastructure layer behind AI agents, our next opportunity comes from Brian, editor of the free daily newsletter Money & Megatrends – and it takes the AI infrastructure story somewhere unexpected…

Brazil.

In Tuesday’s issue of Money & Megatrends, Brian argues the iShares MSCI Brazil ETF (EWZ) is set up to keep climbing, and that AI’s global infrastructure boom is part of the reason why.

Brazil, he notes, is a commodity superpower – and commodities are the backbone of the AI buildout that most investors overlook.

Here he is to explain:

Brazil is a beneficiary of the historic AI infrastructure spending boom…

Brazil’s huge network of rivers also makes it a giant producer of hydroelectric power. This makes it an attractive destination for power-hungry AI data centers.

Brazil also has large reserves of rare earth elements. Demand for these raw materials is soaring thanks to growing demand in AI infrastructure, robotics, and defense tech.

Brian’s been tracking the price action for months. He first flagged Brazilian stocks back in September, and here’s how that call played out:

Soon after my September note, Brazilian stocks – in the form of the iShares Brazil ETF (EWZ) – surged 38% in less than seven months.

It then experienced a natural, healthy bull market correction from mid-April to mid-June.

Now, he says, that correction is over as EWZ looks poised to continue its uptrend.

It’s a reminder that the AI trade isn’t confined to chips and data centers. Somewhere down the supply chain, it runs through rare earths, hydropower, and the raw materials that make the whole buildout physically possible – and Brian thinks Brazil sits right in the middle of that chain.

If you like EWZ, Brian writes Money & Megatrends every day the market is open, highlighting these kinds of opportunities before they become front-page news – and it’s 100% free.

His issues are loaded with trend analysis, actionable advice, and loads of specific tickers. You can sign up right here. 

Louis Navellier: A trade that has nothing to do with AI To round out today’s lineup, let’s turn to Louis, editor of Growth Investor. Two weeks ago, he recommended a trade that’s aging quite well – U.S. oil refiners.

Louis made this call while the ceasefire was still holding. Now that it’s collapsing, the shortages and refining-margin tailwind he flagged look even more likely to persist.

Backing up, volatile crude prices usually squeeze energy companies from both directions…

Rising crude hits refiners’ feedstock costs – the price they pay for the crude oil they’re about to turn into diesel and jet fuel – before they can pass the increase along. Falling crude does the opposite damage – it marks down the value of the crude oil they’re already holding in storage and pipelines.

But right now, refiners are catching a powerful offset: some of the strongest refining margins in years.

Here’s Louis to explain why:

The conflict in the Middle East has created shortages and increased demand for U.S. energy products.

That has pushed refiners to ramp up production of diesel, jet fuel and other petroleum products – and helped drive some of the strongest refining margins in years.

The numbers back him up. In the first quarter, the industry benchmark 3-2-1 crack spread – essentially a snapshot of refiner profitability – jumped 73% on average.

One of the companies riding that tailwind – Louis’ pick – is Phillips 66 (PSX), a diversified energy giant that touches nearly every part of the fuel supply chain. It boasts 12 U.S. refineries, more than 70,000 miles of pipeline, thousands of branded and joint-venture fuel outlets, and a growing renewable fuels business.

That diversification showed up directly in the company’s first-quarter results. Louis highlights how Phillips 66 posted adjusted earnings of $200 million, or $0.49 per share – crushing Wall Street’s estimate for a loss of $0.39 per share.

Analysts have since revised their consensus estimate 60% higher over the past three months, and they now expect second-quarter earnings to soar 179% year-over-year, to $6.64 per share, compared with $2.38 per share in the same quarter a year ago.

Now, Louis made this recommendation on June 26, and his Growth Investor subscribers are already up 11%. That’s pushed PSX above his buy-up-to price of $180 – the stock trades around $189 as I write.

But keep watching here. Any genuine de-escalation in the Middle East would likely ease the shortages driving refining margins higher, which could pull PSX back down – potentially back into Louis’ buy range.

Either way, PSX is a reminder that AI isn’t the only game in town right now. Sometimes the more interesting opportunity is old-fashioned energy infrastructure, catching a tailwind from an entirely different story.

If you want more from Louis, he’s got his eyes on July 23 – exactly two weeks from today – when Q2 earnings kick in.

In his latest presentation, he dives into what his Precursor Intelligence system – or P.I. for short – is digging up right now. Louis designed it to help him identify where institutional money moves next, before the rest of Wall Street catches on. That’s the lens through which he’ll be positioning himself for Q2 earnings.

You can get more details right here – as well as several stocks his system says could be next in line as institutional money makes its next move.

Wrapping up No big headline analysis today – just three ideas to consider from some of our sharpest analysts…

An AI infrastructure trade built for the rebound, A conservative AI angle running through Brazil, And an energy play riding a tailwind that has nothing to do with AI at all. Given our analysts’ respective track records, each is worth a good look if you’re thinking about putting money to work today.

Have a good evening,

Jeff Remsburg

(Disclaimer: I own COHR)

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) will release its second quarter 2026 financial results on Wednesday, August 5, 2026, after the market closes. The earnings news release, financial supplement and related materials will be posted on MetLife's Investor Relations webpage at investor.metlife.com. MetLife will hold its second quarter 2026 earnings conference call on Thursday, August 6, 2026, from 9-10 a.m. (ET) via a live webcast. Please click on the following link to register: ht.

Costco Wholesale Corporation (NASDAQ:COST, XETRA:CTO) shares fell about 4% to $913 on Wednesday after the warehouse retailer reported a moderation in June comparable sales growth, though Bank of America analysts maintained their ‘Buy’ rating, arguing the company's value-focused strategy and affluent customer base should continue to support market share gains.

For the five weeks ended July 5, total sales rose 10.6%, while US comparable sales excluding gasoline increased 7.6%. Bank of America noted the result represented a slowdown on both a one-year and two-year stacked basis following a stronger May.

The analysts wrote that Costco's "philosophy of leading with value and its weighting towards a higher income consumer gives us confidence share gains across categories will continue."

Non-food comparable sales increased by a mid- to high-single-digit percentage, driven by jewelry, home furnishings and major appliances. Management also highlighted higher prices in consumer electronics and appliances due to inflation in memory chip prices.

Fresh food comparable sales rose by a mid-single-digit percentage, supported by bakery and meat, while food and sundries posted low- to mid-single-digit growth led by food, candy and frozen products.

Overall inflation remained in the low- to mid-single-digit range, with food inflation at the lower end due to egg price deflation and non-food inflation at the higher end because of rising memory prices.

Customer traffic increased 3.2% during the month, easing from 3.9% in May, while average ticket growth excluding gasoline and foreign exchange was 3.7%, compared with 4% in the prior month.

Bank of America also noted Costco is now lapping the rollout of extended shopping hours introduced last July for executive members and later for all members. Management previously estimated the additional hours contributed roughly one percentage point to weekly US sales following their introduction.

Elsewhere, ancillary sales growth slowed as gasoline prices eased, while comparable sales growth moderated in Canada and other international markets. Digital comparable sales remained strong, rising 21.5% in June and improving sequentially from the previous month.

The analysts also noted Costco shifted its member appreciation days to coincide with Amazon's Prime Day and other competing promotional events.

Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- Airbnb, Inc. (NASDAQ: ABNB) today announced that the company's second quarter 2026 financial results will be released after market close on August 6, 2026. The company's shareholder letter will be made available on the Airbnb Investor Relations website at https://investors.airbnb.com.

Airbnb will host an audio webcast to discuss its results at 2:00 p.m. PT / 5:00 p.m. ET the same day. The link to the webcast will be made available on the Investor Relations website at https://investors.airbnb.com.

Interested parties can register for the call in advance by visiting https://registrations.events/direct/Q4I66365784. After registering, instructions will be shared on how to join the call.

About Airbnb
Airbnb was born in 2007 when two hosts welcomed three guests to their San Francisco home, and has since grown to over 5.5 million hosts who have welcomed over 2.5 billion guest arrivals in almost every country across the globe. Every day, hosts offer unique stays, experiences, and services that make it possible for guests to connect with communities in a more authentic way.

SOURCE Airbnb, Inc.

Also from this source

Palantir Technologies (PLTR 2.47%) was a retail investor darling in 2023, 2024, and 2025. The stock soared 2,670% during that period, despite Wall Street analysts suggesting the price was already too high for most of it. But the stock has taken a tumble since the end of 2025, dropping roughly 37% from its November 2025 all-time high amid the broader software-as-a-service (SaaS) stock sell-off.

Meanwhile, analysts have begun to take a fresh look at the company as it continues to deliver phenomenal revenue growth and earnings. In fact, despite a recent rally in the stock, the average Wall Street price target is significantly above the current price.

Image source: Getty Images.

How high can Palantir climb? Palantir continues to defy expectations with its revenue growth and improving profitability. Revenue accelerated once again in the first quarter, with its top-line climbing 85% year over year in the first quarter. It's showing particular strength in its U.S. business, and its backlog of remaining deal value shows strong momentum and a long runway for continue revenue growth. Overall, adjusted operating margin expanded to 60%. Management also raised its full-year guidance along with those earnings results.

The software business should continue to produce very strong operating leverage. Its research and development expenses fell to less than 10% of revenue in the first quarter. Meanwhile, the company has taken a strategic approach to sales, letting the software speak for itself for the most part. It has recently turned to boot camps to show companies and their employees how to use Palantir's software to improve operations, a move that has been extremely effective in driving customer acquisition.

Palantir seemingly has no equal to compare its software against. The threat of AI labs supplanting existing enterprise software at a lower cost seems even less likely for Palantir than for more basic software solutions. The core of Palantir is its ontology framework, which enables users to find meaningful connections between disparate data sets. The artificial intelligence built into Palantir's platform isn't easily replicated. As a result, Palantir should see high revenue retention rates.

Today's Change

(

-2.47

%) $

-3.27

Current Price

$

128.95

Execution and growth have never been a problem for Palantir. The biggest concern with the stock has always been its valuation. After the sell-off, the stock trades at 43 times next year's sales expectations and 93 times forward earnings. That's a huge premium over the market. Nonetheless, analysts think it's too cheap.

The median price target for Palantir stock on Wall Street is $200 per share. That price is roughly 54% above the stock's current price as of this writing. And if it reaches that price within 12 months, the stock would trade at roughly the same forward P/E as today, based on analysts' estimates. That suggests Wall Street sees a lot more growth to come for the business.

While management has produced excellent results over the last few years, there's only so long revenue and earnings can accelerate. When the slowdown arrives, the stock could take a hit. Whether you should buy Palantir today depends on whether you think the company can continue to efficiently attract new customers and expand its market at scale.

Micron (MU +4.55%) has lost more than 20% of its value in less than two weeks amid a broader correction among AI stocks. Most investors have been conditioned to expect these sorts of stocks to keep rising steadily, especially as tech giants continue to ramp up their AI infrastructure spending.

The fundamentals of its business suggest Micron's stock rally should continue, so when its price movements defy expectations, it creates buying opportunities for long-term investors.

Image source: Getty Images.

Micron's combination of valuation and revenue growth is rare Micron may be in a class of its own when it comes to valuation and revenue growth. 

In its fiscal 2026 third quarter, which ended May 28, the company more than quadrupled its revenue year over year, blowing past its previous guidance. Even its fiscal fourth-quarter guidance was solid, with more than 20% sequential growth expected.

Today's Change

(

4.55

%) $

43.22

Current Price

$

992.02

Yet the stock trades at a P/E ratio of 22, which is lower than the S&P 500's (^GSPC +0.81%) valuation. Meanwhile, few companies in the benchmark index came anywhere close to that kind of revenue growth. The valuation appears even more absurd when looking at Micron's 6.4 forward P/E ratio. That metric reflects expected future growth, making the current dip all the more jarring.

The company even hinted in its earnings release a few weeks ago that it is breaking free from the cyclical nature of the memory chip business. "Multiyear Strategic Customer Agreements will significantly enhance the durability and predictability of Micron's strong financial performance," said CEO Sanjay Mehrotra.

The fundamentals are strong and strengthening, which makes the recent stock price slide more difficult to justify. It also comes as fellow memory product provider Samsung reported a higher quarterly profit than Apple or Nvidia. Micron is riding that same tailwind and looks poised to expand its market share.

Micron's top customers are rushing to spend more on AI infrastructure The string of strong quarters that Micron has put up lately has not been a fluke. They are the result of the company's largest customers ramping up their AI expenditures and competing with each other to gain market share in lucrative opportunities.

Amazon recently said it would issue at least $25 billion in corporate bonds to raise funds for its AI infrastructure build-out. Meanwhile, Alphabet completed an $84.75 billion equity raise a little earlier.

This spending comes from highly profitable companies that are scaling up their products and services thanks to AI. A meaningful portion of the money raised by their financial moves should flow rapidly into Micron's coffers since AI servers require copious amounts of memory chips.

Micron is even well positioned for the expected push into physical AI. Humanoid robots and self-driving vehicles will also need Micron's memory chips. While hyperscalers' big deals get the most attention, Micron also struck a multiyear agreement with Ford Motor Company to supply the memory products for its next-gen vehicles. Deals can branch well beyond tech giants as more industries embrace AI. It all bodes well for Micron despite the recent stock price action.

Marc Guberti has positions in Apple. The Motley Fool has positions in and recommends Alphabet, Amazon, Apple, Micron Technology, and Nvidia. The Motley Fool has a disclosure policy.

, /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Zillow Group, Inc. ("Zillow" or the "Company") (NASDAQ: Z, ZG) have opportunity to lead the securities fraud class action lawsuit.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ZILLOW GROUP, INC. (Z, ZG), CLICK HERE BEFORE AUGUST 10, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

What Is The Lawsuit About? 
The complaint filed alleges that, between February 11, 2025 and May 7, 2026, Defendants failed to disclose to investors that: (1) Zillow's agreement with Redfin was not a "partnership," but rather an acquisition of Redfin's business; (2) as a result of the Redfin Agreement, Zillow faced a materially heightened risk of regulatory scrutiny and liability under federal antitrust laws; (3) upon the filing of an antitrust lawsuit, Zillow continued to downplay its legal exposure; and (4) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Contact Us To Participate or Learn More: 
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
The Law Offices of Frank R. Cruz, 
Email us at: [email protected]
Call us at: 310-914-5007
Visit our website at: www.frankcruzlaw.com
Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

SOURCE The Law Offices of Frank R. Cruz, Los Angeles

HomeDividends AnalysisDividend IdeasConsumer Staples Analysis

SummaryPhilip Morris International Inc. remains a Hold, driven by strong business fundamentals but limited upside due to valuation premium.PM's smoke-free products will soon comprise 50% of business, underpinning long-term growth and differentiation from peers.I expect Q2 2026 to show improved organic growth and EPS growth exceeding 8%, outpacing consensus.Despite operational strength and dividend reliability, PM's ~22x forward P/E limits total return potential to below 10%. tadamichi/iStock via Getty Images

After I first covered Philip Morris International Inc. (PM), I bought my first shares in that business. Since that article (I linked it above), PM's stock price has jumped by over 70%. And I'm happy to say

5.16K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of PM, MO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

The information, opinions, and thoughts included in this article do not constitute an investment recommendation or any form of investment advice.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Investors choosing between Invesco Aerospace & Defense ETF (PPA 0.34%) and ARK Space & Defense Innovation ETF (ARKX +0.05%) may weigh the lower costs of PPA against the more aggressive, technology-focused strategy of ARKX.

Both funds target the final frontier, but they take different trajectories. Invesco Aerospace & Defense ETF tracks a concentrated index of domestic aerospace and defense companies, providing exposure to traditional military contractors. In contrast, ARK Space & Defense Innovation ETF is an actively managed fund that casts a wider, more speculative net across orbital and suborbital technologies.

Snapshot (cost & size)MetricARKXPPAIssuerARKInvescoShare price$32.30 (as of 2026-07-08)$175.51 (as of 2026-07-08)Expense ratio0.75%0.58%1-yr return (as of 2026-07-08)33.7%24.6%Dividend yieldNone0.4%Beta1.410.74AUM$1.1B$8.6BBeta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.

ARK Space & Defense Innovation ETF charges 0.75%, making it the more expensive option compared to the 0.58% fee for Invesco Aerospace & Defense ETF. These costs represent the annual management fees deducted from fund performance to cover administrative and oversight expenses.

Performance & risk comparisonMetricARKXPPAMax drawdown (4 yr)(25.6%)(15.4%)Growth of $1,000 over 4 years (total return)$2,337$2,557What's insideThe Invesco Aerospace & Defense ETF is an industrials-heavy portfolio with approximately 90% of assets concentrated in that sector. Its largest positions include GE Aerospace (GE +0.84%)at 7.3%, RTX Corp (RTX +0.15%) at 7.2%, and Boeing Co. (BA 0.82%) at 7.1%. It holds 62 different securities and was launched in 2005. It focuses on companies systematically important to U.S. national security and government space operations, favoring established firms with significant defense contracts.

The ARK Space & Defense Innovation ETF leans more toward the technology sector, which accounts for 24% of its weight, although industrials still represent 59% of the portfolio. Its top holdings include Space Exploration Technologies (SPCX +2.60%) at 8.8%, L3Harris Technologies (LHX 1.38%) at 6.5%, and Rocket Lab Corp at 6.4%. It holds 45 securities and was launched in 2021. It seeks long-term capital appreciation by investing in companies leading orbital and suborbital space innovation, including firms that use satellite technology for terrestrial applications such as precision agriculture.

Which fund is the better buy?While these ETFs cover the same sector, they differ significantly from one another.

The key difference between the Invesco Aerospace & Defense ETF — PPA — and the ARK Space & Defense Innovation ETF — ARKX — is that PPA is a passively managed ETF meant to reflect an index, the SPADE Defense Index, while ARKX  is actively managed, meaning a person or team is making decisions to shift assets among its investment landscape. Indeed, the weightings of ARKX’s top 10 holdings change frequently, such as the addition of SpaceX since its IPO on June 12.

The active hand is paying off. The year-to-date return of ARKX is about 11.5%, with a 33.7% one-year return. PPA has performed decently, with year-to-date and 1-year returns of 12.2% and 24.6%, respectively.

Longer-term PPA has respectable 5-year and 10-year returns of 19.4% and 17.8%, respectively. ARKX has a 10.2% 5-year return (and no 10-year return given its age).

The long-term results of PPA are a strong argument for that fund. But If you trust that the active managers who have posted a good 1-year return are acting on skill and insight, then the ARK Space & Defense Innovation ETF is the better choice.

For more guidance on ETF investing, check out the full guide at this link.

Brendan Coffey has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Boeing, Deere & Company , GE Aerospace, L3Harris Technologies, and RTX. The Motley Fool has a disclosure policy.

The Coinbase logo on a smartphone screen in this illustration taken November 3, 2025. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab

CompaniesWASHINGTON, July 9 (Reuters) - Coinbase (COIN.O), opens new tab's Chief Legal Officer Paul Grewal is stepping down after six years at the U.S. crypto giant where he fought off a landmark suit ​brought by the U.S. securities regulator and played an instrumental role in the crypto industry's Washington ‌campaign to secure industry-friendly policies.

Grewal will step down effective immediately, with Molly Abraham, Coinbase's vice president of legal, moving into his role with the title of general counsel, the company told Reuters. Coinbase is also naming Ryan VanGrack, who is currently vice president ​of legal, as the company's first vice chair and head of corporate affairs, Coinbase said.

The Reuters Daily Briefing newsletter provides all the news you need to start your day. Sign up here.

Grewal first ​posted news of his departure on X.

Grewal's time at Coinbase was partly defined by a ⁠years-long legal battle with the Securities and Exchange Commission, which sued Coinbase in 2023 alleging the company had flouted ​its rules by facilitating trading in crypto tokens that it said should have registered as securities with the watchdog.

Legal ​experts saw the case as existential for Coinbase and the broader crypto industry, which had long sought to avoid costly SEC oversight. The agency under U.S. President Donald Trump, who courted crypto money on the campaign trail, dismissed the case last year, a massive ​win for Grewal, Coinbase and the industry.

Coinbase has been a top advocate for the crypto industry as it has ​sought policy changes in Washington to put it on a solid legal footing, with Grewal at the forefront of those efforts.

Most ‌recently, ⁠he had also been involved in deliberations on highly anticipated legislation -- dubbed the Clarity Act -- that would create federal rules for cryptocurrencies. The bill had been bogged down for months by a dispute between crypto companies and banks, but advanced out of a key Senate committee in May.

"After helping to take the company public, fighting the SEC and winning, ​moving us from Delaware to ​Texas, working to get ⁠GENIUS and soon CLARITY passed into law, and so much more – now is my time for new adventures," Grewal said in a post on X.

In his new role, ​VanGrack, who will be second-in-command to CEO Brian Armstrong, will step into a "broader corporate ​and public-facing role" ⁠representing Coinbase before "key stakeholders and policymakers around the world," he said in an interview.

The company needs to focus "on steps that unlock products, expand jurisdictions, and enhance our relationships with governments and partners around the world," VanGrack added.

The shift comes ⁠as Coinbase ​looks to become an "everything exchange" by expanding beyond crypto, including into ​stock trading, prediction markets and artificial intelligence-powered investment tools.

“What I'm so excited about in this next chapter is this is all about building our ​products... because of the path that [Grewal] cleared," said Abraham in an interview.

Reporting by Hannah Lang; editing by Michelle Price

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Hannah Lang covers financial technology and cryptocurrency, including the businesses that drive the industry and policy developments that govern the sector. Hannah previously worked at American Banker where she covered bank regulation and the Federal Reserve. She graduated from the University of Maryland, College Park and lives in Washington, DC.

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TBPH, IRDM, LCII, and PATK PR Newswire

WILMINGTON, Del., July 09, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Wednesday, August 5, 2026. The Company’s management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company’s business and financial performance for the quarter.

Second Quarter 2026 Conference Webcast Details:

What: Clover Health’s Second Quarter 2026 Earnings Conference CallWhen: Wednesday, August 5, 2026, at 5:00 p.m. Eastern TimeWebcast: To access the webcast, you may register at https://clover-health-2q-2026-earnings.open-exchange.net/.
A live and archived webcast of the conference call will also be accessible from the Investor Relations section of Clover Health’s website at https://investors.cloverhealth.com/ for 12 months.

About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and in Underserved Populations as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.

Investor Relations:
Ryan Schmidt
[email protected]

Press Inquiries:
[email protected]

DALLAS--(BUSINESS WIRE)--Atmos Energy Corporation (NYSE: ATO) will host a conference call on Thursday, August 6, 2026, at 10 a.m. Eastern to review the company's Fiscal 2026 third quarter financial results. Atmos Energy will release these results on Wednesday, August 5, 2026, following the market close. To listen to the conference call, please dial either the toll-free or international number provided below. You may also listen to the call on the Atmos Energy website at www.atmosenergy.com. The.

, /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to ZoomInfo Technologies Inc. ("ZoomInfo" or the "Company") (NASDAQ: GTM) have opportunity to lead the securities fraud class action lawsuit.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ZOOMINFO TECHNOLOGIES INC. (GTM), CLICK HERE BEFORE AUGUST 24, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

What Is The Lawsuit About? 
The complaint filed alleges that, between November 3, 2025 and May 11, 2026, Defendants failed to disclose to investors that: (1) ZoomInfo's optimistic plan for continued growth was undermined by slowing seat-based demand, weakening upsells and customers revising decisions to purchase AI products and develop internal AI-driven go-to-market solutions, making ZoomInfo's 2026 full year revenue guidance increasingly unlikely to be met; and (2) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
The Law Offices of Frank R. Cruz, 
Email us at: [email protected]
Call us at: 310-914-5007
Visit our website at: www.frankcruzlaw.com
Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

SOURCE The Law Offices of Frank R. Cruz, Los Angeles

Store

SubscribeSign In

My Subscriptions

Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD LiveCustomer Center

My Stock Lists

Email Preferences

Help & Support

Sign Out

Search stocks or keywords

Sections

My IBD

MARKET TREND

STOCK LISTS

STOCK RESEARCH

NEWSECONOMY

VIDEOS & PODCASTS

HOW TO INVESTEDUCATIONAL RESOURCESStoreMy Products

Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD Live

Recently Searched

AMD, Micron Spearhead Chip Sector Surge, Lead 23 Hot Prospects To Best Stock Lists

2026: A Space Stock Odyssey

Stock Market Mixed As Chips Rise While Small Caps, Dow, SpaceX Struggle; Ned Davis On Cash Dell Technologies (DELL) stock approached a buy point on Thursday after getting a price-target hike from a Wall Street analyst and an endorsement from President Donald Trump. On the stock market today, Dell stock rose 4.2% to close at 450.22. After this week, Dell stock is on track to have a new base with a 469.47 buy point, based on…

Copyright ©2026 Investor's Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8

Key Takeaways Micron expects fiscal Q4 2026 revenues of about $50B after a strong fiscal Q3. MU lifted fiscal Q3 gross margin to 84.6%, supported by AI memory demand and pricing. WDC expects fiscal Q4 2026 revenues of about $3.65B, with gross margin of 51-52%. Artificial intelligence (AI) infrastructure stocks have faced significant pressure this month as investors questioned whether the pace of AI spending would remain strong. However, the long-term AI demand remains intact, supported by strong demand for graphics processing units, networking equipment, memory and storage.  

Therefore, for long-term investors, the recent pullback could present an attractive investment opportunity. Among the standout AI infrastructure stocks are Micron Technology, Inc. (MU - Free Report) and Western Digital Corporation (WDC - Free Report) , whose shares have surged by 229.3% and 214.7%, respectively, so far this year. Let’s see in detail what makes these companies a strong buy now, and why they still have significant upside potential –  

Micron’s AI Memory Boom Drives Growth and Upside Potential Micron’s stock wobbled recently due to post-fiscal third-quarter 2026 earnings profit-taking and concerns about the sustainability of the present high memory prices. But Micron has emerged as an essential supplier of AI infrastructure and is no longer considered a cyclical memory stock. The company’s fundamentals remain intact as its recent quarterly results beat expectations, and its outlook remains strong, driven by robust AI memory demand. 

Micron reported revenues of $41.46 billion in the fiscal third quarter of 2026, a 74% sequential increase, according to investors.micron.com. For the fiscal fourth quarter of 2026, the company expects revenues of $50 billion, suggesting that demand for Micron’s state-of-the-art high-bandwidth memory chips used in AI servers remains strong. Growing demand for Micron’s memory products and strong pricing power boosted its profitability, with gross margin improving to 84.6% for the fiscal third quarter from 37.7% a year earlier.  

Micron’s strong cash inflows and strategic deals have further enhanced its long-term revenue visibility and reinforced its growth outlook. Consequently, the company’s expected earnings growth rate for the current year is 791%. The Zacks Consensus Estimate of $73.86 for MU’s earnings per share is up 502% year over year.

 

Image Source: Zacks Investment Research

Brokers also remain hopeful about the company’s prospects. The average short-term price target for MU stock stands at $1,422.77, implying a potential upside of 51.6% from the recent closing price of $938.38. The highest price target of $2,000 indicates a possible upside of 113.1%, highlighting strong investor confidence in Micron’s long-term growth outlook (read more: Micron Stock Drops 10%+ After Earnings - Is This a Buying Opportunity?).

 

Image Source: Zacks Investment Research

Western Digital: Strong AI Demand Fuels More Upside Western Digital’s revenues totaled $3.34 billion in the fiscal third quarter of 2026, up 45% year over year, according to the company’s press release. Revenues are expected to be even stronger in the fiscal fourth quarter of 2026, at $3.65 billion, plus or minus $100 million. The strong outlook suggests that AI infrastructure spending remains robust, as cloud and enterprise customers continue to invest heavily in high-capacity storage to support expanding AI workloads. 

Western Digital’s non-GAAP gross margin increased to 50.5% in the fiscal third quarter from 40.1% in the year-ago period. What’s more, management expects non-GAAP gross margin to expand further to 51-52% in the fiscal fourth quarter of 2026. This shows the company can sell more high-value enterprise HDDs amid a favorable pricing environment. Higher gross margins also provide greater financial flexibility to invest in research and development, strengthen the balance sheet, drive earnings growth and boost the share price over the long run. 

The company’s earnings outlook remains equally strong, with expected earnings growth of 104.1% for the current year. The Zacks Consensus Estimate of $10.06 for WDC’s earnings per share is up 54.8% year over year.

 

Image Source: Zacks Investment Research

Brokers are also optimistic about Western Digital’s growth prospects. They forecast the average short-term price target for WDC stock at $608.27, implying a 14.3% increase from the last closing price of $532.1. The highest target is $1,050, suggesting a potential upside of 97.3%, highlighting continued confidence in Western Digital’s long-term growth potential.

 

Image Source: Zacks Investment Research

Both Micron and Western Digital have a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks Rank #1 stocks here.

© David McNew / Getty Images

Jeff Bezos spent a quarter-century building Blue Origin with his own money. Now, outside investors are finally getting a chance to get a seat at the table.

Video Muted

During a recent TBPN discussion, John Coogan broke down Blue Origin’s reported $10 billion fundraising round at a $130 billion valuation, which is the company’s first external capital raise after 25 years of self-funding. The deal is notable not just for its size, but also for offering one of the clearest windows yet into how private markets are valuing next-generation space companies.

The Deal: A $10 Billion Raise at a $130 Billion Valuation According to Coogan, Blue Origin is raising $10 billion at a $130 billion valuation. The scoop, he noted, came from Andrew Ross Sorkin at The New York Times.

The mechanics are unusual. Bezos is personally putting in $2 billion, and Coatue Management, led by Philippe Laffont, is receiving a $4 billion allocation. That is a striking arrangement given that, as Coogan pointed out, Bezos’s family office is already a major investor in Coatue’s Innovative Strategies Fund, so they already have a close relationship.

Coogan’s read on the dynamic was blunt: “People can’t really complain about the valuation, ’cause he’s a big part of setting the price.” Jeff Bezos himself is investing at this valuation and steering capital toward a fund he already backs.

Why Investors Are Valuing Capability Over Current Cash Flows Blue Origin’s burn rate is enormous. Coogan cited that the company has burned roughly $27 billion to date and is estimated to have burned $5 billion in 2025 alone, making this $10 billion a standard 12-to-18-month runway raise. The valuation rests on capability rather than revenue or free cash flow.

Coogan argued the $130 billion figure reflects Blue Origin’s status as the second company in the world to bring a rocket to orbit, land it successfully, and prove reusability, ahead of China. That is a strategic asset with a very short list of owners on Earth, and pricing it looks nothing like pricing a software business on ARR multiples.

For investors trying to make sense of how private markets are pricing hard-tech moats in 2026, Blue Origin sits at the extreme end of a spectrum that also includes AI infrastructure and next-generation power. For readers interested in how AI power demand and infrastructure could create new opportunities, our team’s Free Report: 7 Stocks Powering the AI Boom (That Aren’t Chipmakers) is worth reading.

The Space Comp Set Coogan grounded the valuation in the public space comps. He noted Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) sits at just under a $50 billion market cap and AST SpaceMobile (NASDAQ:ASTS) sits at around $30 billion. Against those marks, a $130 billion tag for the second reusable-orbit operator on the planet feels aggressive but makes sense.

The historical parallel Coogan reached for was ridesharing. He compared the moment to Uber (NYSE:UBER)’s once-unprecedented $17 billion private valuation, which now “looks quaint.” Private-market ceilings for category-defining companies keep resetting higher, and what feels absurd in the moment often becomes a footnote once the business scales.

What to Watch Next Whether Blue Origin ultimately justifies a $130 billion valuation remains an open question. What is already clear is that private investors are increasingly assigning enormous value to companies with difficult-to-replicate technological capabilities rather than near-term profits.

The next milestones will be whether additional institutions invest alongside Coatue, whether Blue Origin improves New Glenn launch cadence, and how private-market valuations for SpaceX and other space companies respond. Even without direct access to either company, those ripple effects could shape valuations across the broader space sector.

Contact [email protected] for any questions or corrections.

Key Takeaways Agilent is expanding its AI software and automation portfolio to support its biopharma growth prospects. Agilent launched xCELLigence RTCA eSight AI to simplify label-free live-cell imaging analysis. A expects fiscal Q3 2026 revenues of $1.83B-$1.85B, implying 5.0%-6.5% reported growth. Agilent Technologies (A - Free Report) shares have lost 5.2% in the year-to-date period, underperforming the Zacks Medical  industry's 2.8% growth. The dip reflects cautious laboratory spending and a challenging macroeconomic environment.

However, Agilent continues to strengthen its long-term growth prospects through product innovation and expanding artificial intelligence (AI)-enabled laboratory software and automation capabilities, supported by healthy demand across the pharmaceutical, diagnostics and advanced materials markets.

The company also benefits from growing demand for AI-enabled laboratory software and automation as pharmaceutical and biotechnology companies increasingly digitize research workflows and accelerate drug discovery. Agilent's integrated software ecosystem, led by its OpenLab and xCELLigence platforms, combines analytical instruments, software and laboratory automation to improve productivity, reduce manual intervention and deliver more consistent scientific results.

Agilent Expands AI-Powered Cell Analysis PortfolioAgilent continues to strengthen its AI-enabled laboratory portfolio through innovations spanning analytical instruments, laboratory software, automation and digital workflows, supporting the growing adoption of AI-driven research solutions.

Building on this strategy, the company launched xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free live-cell imaging analysis. The software enhances the xCELLigence RTCA eSight platform by combining AI-driven image analysis with impedance measurements, enabling researchers to analyze imaging and cell behavior simultaneously from the same experiment.

The new module replaces manual cell segmentation and subjective parameter tuning with a one-click automated workflow, helping researchers generate more consistent and reproducible results while reducing analysis time and lowering training requirements. Designed for drug discovery and high-throughput biopharma research, the software is expected to accelerate scientific workflows, improve laboratory productivity and expand adoption of Agilent's integrated cell analysis platform, supporting long-term software and biopharma growth.

AI Innovation Strengthens Agilent's Growth StoryAgilent continues to expand its AI capabilities across laboratory software, automation and digital workflows. During the second quarter of fiscal 2026, AI was highlighted as a key long-term growth driver, with increasing customer adoption and continued investments in digital laboratory solutions expected to support sustainable growth. Agilent is integrating AI across its analytical instruments, laboratory informatics and automation solutions to enhance scientific workflows and operational efficiency.

Agilent is further expanding its digital laboratory capabilities through its announcement of the China Innovation Center in June 2026, which focuses on AI, automation and digital laboratory technologies to enable next-generation smart laboratories. These initiatives strengthen Agilent's AI-enabled laboratory portfolio and are expected to address growing demand for AI-powered laboratory software and automation solutions, strengthening the company's long-term growth prospects.

Agilent Provides Strong Fiscal Q3 2026 OutlookAgilent's improving demand environment, expanding AI software portfolio and continued product innovation are expected to benefit the company’s top-line growth.

For the third quarter of fiscal 2026, A expects revenues to be in the range of $1.83-$1.85 billion, implying 5.0%-6.5% reported growth and 4.4%-5.9% core growth.

The Zacks Consensus Estimate for third-quarter fiscal 2026 revenues is pegged at $1.84 billion, indicating year-over-year growth of approximately 6.02%.

The consensus estimate for third-quarter fiscal 2026 earnings is pegged at $1.47 per share, which has decreased by a penny over the past 30 days, indicating year-over-year growth of 7.30%.

A’s Zacks Rank & Stocks to ConsiderCurrently, Agilent carries a Zacks Rank #3 (Hold).

Fortrea Holdings Inc (FTRE - Free Report) , Neurocrine Biosciences (NBIX - Free Report) and PTC Therapeutics (PTCT - Free Report) are some better-ranked stocks that investors can consider in the broader Zacks Medical sector. Fortrea Holdings Inc, Neurocrine Biosciences and PTC Therapeutics sport a Zacks Rank #1 (Strong Buy) each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

FTRE shares have lost 1.4% in the year-to-date period. The long-term earnings growth rate for Fortrea Holdings is pegged at 40.91%.

NBIX shares have risen 25.6% in the year-to-date period. The long-term earnings growth rate for Neurocrine Biosciences is pegged at 33.41%.

Shares of PTCT have gained 16.6% in the year-to-date period. The long-term earnings growth rate for PTC Therapeutics is pegged at 27.74%.

4.59K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Store

SubscribeSign In

My Subscriptions

Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD LiveCustomer Center

My Stock Lists

Email Preferences

Help & Support

Sign Out

Search stocks or keywords

Sections

My IBD

MARKET TREND

STOCK LISTS

STOCK RESEARCH

NEWSECONOMY

VIDEOS & PODCASTS

HOW TO INVESTEDUCATIONAL RESOURCESStoreMy Products

Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD Live

Recently Searched

AMD, Micron Spearhead Chip Sector Surge, Lead 23 Hot Prospects To Best Stock Lists

2026: A Space Stock Odyssey

Stock Market Mixed As Chips Rise While Small Caps, Dow, SpaceX Struggle; Ned Davis On Cash France-based TotalEnergies (TTE) announced on Wednesday that it has shipped the first liquefied natural gas from a newly built Mexico export terminal to Asia. But TotalEnergies, and LNG stocks in general, fell. TotalEnergies and a Sempra (SRE) subsidiary hold joint stakes in the Energia Costa Azul LNG hub, along Mexico's Pacific coast on the Baja peninsula. The Energia Costa Azul…

Copyright ©2026 Investor's Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8

Nvidia is still leading the AI revolution. But it may not be the best way to invest in it anymore.

Invesco Pharmaceuticals ETF (PJP 0.41%) offers a less volatile, concentrated pharmaceutical focus with higher yield, whereas State Street SPDR S&P Biotech ETF (XBI +0.80%) provides high-growth, equal-weighted biotechnology exposure at a lower cost.

Investors seeking healthcare exposure often choose between the higher volatility of biotechnology and the established stability of major pharmaceuticals. This comparison explores how XBI and PJP balance risk, total return, and diversification within the medical and life sciences sectors.

Snapshot (cost & size)MetricXBIPJPIssuerSPDRInvescoShare price$162.97 (as of 2026-07-08)$120.94 (as of 2026-07-08)Expense ratio0.35%0.57%1-yr return (as of 2026-07-08)93.3%50.3%Dividend yield0.30%0.90%Beta0.820.45AUM$10.9 billion$361.3 millionBeta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.

The Invesco fund is more costly to hold with a 0.57% expense ratio compared to 0.35% for the SPDR fund. However, the Invesco fund provides a higher yield for investors who prioritize regular income distributions.

Performance & risk comparisonMetricXBIPJPMax drawdown (5 yr)(54.00%)(17.50%)Growth of $1,000 over 5 years (total return)$1,226$1,581What's insideThe Invesco Pharmaceuticals ETF is a non-diversified fund that generally invests at least 90% of its total assets in U.S. pharmaceutical companies. Its portfolio of 30 holdings focuses on businesses involved in the research, development, and distribution of various drugs. Its largest positions include AbbVie (ABBV 1.12%) at 5.6%, Eli Lilly & Co (LLY 0.01%) at 5.4%, and Johnson & Johnson (JNJ 1.87%)at 5.3%. The fund was launched in 2005.

State Street SPDR S&P Biotech ETF follows the S&P Biotechnology Select Industry Index using a representative sampling technique. Its sector focus is also all healthcare, and its top holdings include Apogee Therapeutics (APGE +0.24%) at 1.5%, Moderna (MRNA +3.77%) at 1.4%,and Twist Bioscience (TWST +4.80%) at 1.36%. This portfolio contains 155 holdings. The fund was launched in 2006. State Street SPDR S&P Biotech ETF has paid $0.57 per share over the trailing 12 months, which, on its recent ~$163 share price, works out to a 0.30% yield.

While both are healthcare ETFs, they differ notably in style and performance.

The Invesco Pharmaceutical ETF — PJP — has a concentrated focus just on drugmakers, which has allowed it to capitalize on the GLP-1 boom, led by its second-largest holding, Eli Lilly. It’s largely large-cap and small-cap stocks, with 86% of holdings evenly split between the two, with the balance in mid-caps.

The State Street SPDR S&P Biotech ETF — XBI — is 81% small-cap stocks and just 5% large-cap stocks, which has enabled it to profit from the best year for small-cap stocks since 1991. In addition to its 93% one-year gain, it has returned 24.1%, 3.3%, and 11.5% over the 3-year, 5-year, and 10-year time frames, respectively. PJP, meanwhile, lags XBI in every time frame but the 5-year, where it boasts a 9.1% annualized return.

XBI does come with a word of caution, though. It’s 54% maximum drawdown is a gut-wrenching drop, even if it is just on paper. Still, the long-term performance and the fact that it has been able to capture the small-cap rally, too, makes XBI the ETF to buy.

For more guidance on ETF investing, check out the full guide at this link.

Brendan Coffey has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends AbbVie, Eli Lilly, Moderna, and Twist Bioscience. The Motley Fool recommends Johnson & Johnson, Kymera Therapeutics, and SPDR Series Trust - SPDR S&P Biotech ETF. The Motley Fool has a disclosure policy.

BOSTON, July 09, 2026 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) today announced that it will release operating results for the third quarter of fiscal 2026 on Monday, August 3, 2026, after the market close. The Company will host a conference call and live webcast to review the third quarter results beginning at 8:00 AM (ET) on Tuesday, August 4, 2026.

The call will be webcast by Notified and may be accessed through Cabot’s website at https://cabotog.gcs-web.com/. If you are unable to participate during the live webcast, the call and accompanying slide presentation will be archived in the Investor Relations section of the Company’s website at https://cabotog.gcs-web.com/.

ABOUT CABOT CORPORATION
Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company is a leading provider of reinforcing carbons, specialty carbons, battery materials, engineered elastomer composites, inkjet colorants, masterbatches and conductive compounds, fumed metal oxides and aerogel. For more information on Cabot, please visit the company’s website at cabotcorp.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in the press release regarding Cabot's business that are not historical facts are forward looking statements that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2025.

Students from Free All Minds and Women of the Dream will participate in hands-on career exploration, workforce readiness and mentorship July 14-16 in Camden

, /PRNewswire/ -- New Jersey American Water today announced the launch of the 2026 Flow Forward Summer Camp Program in Camden, offering high school students from Free All Minds and Women of the Dream a three-day workforce development experience featuring hands-on learning, mentorship, resume and interview preparation, and networking with water industry professionals.

The program will be hosted July 14-16 at American Water's headquarters on the Camden Waterfront and New Jersey American Water's Delaware River Regional Water Treatment Plant in Delran. With American Water headquartered in Camden, Flow Forward reflects the company's continued commitment to investing in local youth, expanding career awareness and strengthening connections with the community it calls home.

Flow Forward is American Water's summer career exploration program designed to help high school sophomores, juniors and seniors learn more about the water and wastewater industry, gain practical experience and connect with employees who can share insights into career pathways across the company. Through the Camden program, students will explore how safe, reliable water service is delivered, learn about the role New Jersey American Water plays in communities across the state, and see how careers in operations, engineering, water quality, customer service, government affairs, finance and communications can support public health and local communities.

During the camp, students will participate in sessions focused on communication skills, resume building, transferable skills, mock interview preparation and networking. They also will take part in breakout discussions with employees from across the business, tour the Delaware River Regional Water Treatment Plant, hear employee career stories and work in teams on final project presentations.

Camden Mayor Victor Carstarphen will join New Jersey American Water President Mark McDonough on the first day of the program to welcome students and underscore the importance of early career exposure, mentorship and community partnership.

"We are proud to welcome students from Free All Minds and Women of the Dream to Flow Forward here in Camden," said Camden Mayor Victor Carstarphen. "When young people are given the chance to see what is possible, meet professionals who believe in them and explore careers they may not have considered before, it can change the way they see their future. Programs like this help open doors for Camden students while connecting them to meaningful career pathways that serve our community."

"Camden is home to American Water, but our commitment goes beyond having an address here," said Mark McDonough, president of New Jersey American Water. "We want to be part of the community in a way that is visible, meaningful and lasting. Flow Forward is a chance to bring Camden students inside our business, introduce them to careers they may not have seen up close before and show them that the work happening here connects directly to the neighborhoods where they live."

Flow Forward reflects New Jersey American Water's commitment to creating awareness of water industry careers, supporting local talent pipelines and helping Camden students gain the exposure, confidence and professional skills that can prepare them for future success. For more information about the company's efforts around workforce development, visit newjerseyamwater.com, under About Us, select Workforce Development.

About New Jersey American Water
New Jersey American Water, a subsidiary of American Water (NYSE: AWK), is the largest regulated water utility in the state, providing safe, clean, reliable and affordable water and wastewater services to approximately 3 million people. For more information, visit www.newjerseyamwater.com and follow New Jersey American Water on LinkedIn, Facebook, X and Instagram.

SOURCE American Water